AI assistant
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Mar 28, 2011
33422_dirs_2011-03-28_a73d32b9-9974-42fe-9881-4e84e2ddd507.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRO PHARMACEUTICALS INC (PRWP.OB)
CIK: 0001133416
Period of Report: 2011-03-24
Reporting Person: ZUCCONI THEODORE DANIEL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-24 | Common Stock | M | 370000 | $0.23 | Acquired | 466343 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-24 | Employee Stock Option (Right to Buy) | $0.23 | M | 370000 | Disposed | 2014-03-24 | Common Stock (370000) | Direct |
Footnotes
F1: Includes 58,245 shares held in retirement accounts for the reporting person.
F2: Includes 3,998 shares held in retirement accounts for the wife of the reporting person, who disclaims beneficial ownership of such shares to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such share for the purpose of Section 16 or otherwise.
F3: The option, representing a right to purchase 500,000 shares, became exercisable in installments and is fully exercisable as of March 24, 2011.